Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 14, 2015; 21(34): 9974-9981
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9974
Table 1 Patient characteristic
n76
Sex (M:F)60:16
Age at diagnosis (yr)124 (11-71)
Age at DBE (yr)136 (16 -71)
Disease duration (yr)17.5 (0-33)
Disease location (L1:L2:L3)16:28:32
Prior surgery40
Disease behavior (B1:B2:B3)27:43:6
CDAI2106.7 ± 54.6
Medication at DBE
Infliximab29
Azathioprine18
Elemental diet61
5-ASA63
No medication4
Table 2 Comparison of clinical variables between the low and high modified Simple Endoscopic Score for Crohn’s disease groups
mSES-CDLow (< 4)High (4)P value
Number1660
Sex (Male:Female)15:145:150.092
Mean age at diagnosis (yr)27.2 ± 8.925.8 ± 11.00.648
Mean disease duration (yr)13.1 ± 8.09.0 ± 8.80.097
Prior surgery (yes/no)10:630:300.374
Infliximab (yes/no)8:821:390.272
Azathioprine (yes/no)2:1416:440.200
Elemental diet (yes/no)14:247:130.335
5-ASA (yes/no)15:148:120.180
CDAI90.0 ± 55.4111.0 ± 54.10.186
CRP (mg/dL)0.16 ± 0.211.13 ± 1.57< 0.001
Albumin (g/dL)4.01 ± 0.823.47 ± 0.720.010
Table 3 Univariate and multivariate analyses for surgery-free survival (n = 76)
Univariate analyses
Multivariate analyses
HR95%CIP valueHR95%CIP value
mSES-CD≥ 47.591.03-56.00.0479.381.20-73.50.033
SES-CD≥ 41.340.60-3.020.477-
SexMale0.970.39-2.420.942-
Age at diagnosis< 201.070.48-2.350.876-
Disease duration≥ 102.210.98-4.810.0562.751.18-6.450.020
Prior surgeryYes1.520.69-3.340.303-
Albumin< 41.530.64-3.630.340-
Platelet≥ 410 × 1041.910.76-4.770.166-
CRP≥ 0.31.560.72-3.380.259-
WBC≥ 85001.420.42-4.720.572-
CDAI≥ 1501.850.80-4.300.151-
InfliximabYes0.340.13-0.900.0290.310.12-0.830.019
5-ASAYes1.120.42-2.970.822-
Elemental dietYes1.410.48-4.100.530-
AzathioprineYes0.660.25-1.760.408-
Disease locationColorectum0.380.11-1.270.114-
Colorectum + Small intestine2.171.00-4.690.050Excluded
Small intestine0.910.41-2.020.824-